Profile
David W.
Pritchard served as President, Chief Executive Officer & Director at Humanigen, Inc. from 2006 to 2014.
Prior to that, he was the Chief Financial Officer & VP-Business Development at CymaBay Therapeutics, Inc. from 1992 to 2000.
He also held positions at Matrix Pharmaceutical, Inc. and Rinat Neuroscience Corp.
as Chief Financial Officer and Chief Business Officer, respectively.
Additionally, he worked as a Principal at Triton Biosciences, Inc. Pritchard holds an MBA from Stanford University and an undergraduate degree from Cornell University.
Former positions of David W. Pritchard
Companies | Position | End |
---|---|---|
HUMANIGEN, INC. | Chief Executive Officer | 2014-01-07 |
CYMABAY THERAPEUTICS, INC. | Director of Finance/CFO | 1999-12-31 |
Triton Biosciences, Inc. | Corporate Officer/Principal | - |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Director of Finance/CFO | - |
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Corporate Officer/Principal | - |
Training of David W. Pritchard
Cornell University | Undergraduate Degree |
Stanford University | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Listed companies | 1 |
---|---|
HUMANIGEN, INC. | Health Technology |
Private companies | 4 |
---|---|
Rinat Neuroscience Corp.
Rinat Neuroscience Corp. BiotechnologyHealth Technology Rinat Neuroscience Corp. manufactures and markets drugs for treating neurological diseases. The company was founded by Arnon Rosenthal and Patrick G. Lynn on November 21, 2000 and is headquartered in South San Francisco, CA. | Health Technology |
Matrix Pharmaceutical, Inc.
Matrix Pharmaceutical, Inc. Medical SpecialtiesHealth Technology Matrix Pharmaceutical, Inc. is a company that researches and develops pharmaceutical products. The company is based in Fremont, CA. The company was founded in 1985 by Dennis M. Brown. Matrix Pharmaceutical was acquired by Chiron Corp. on February 19, 2002 for $58.63 million. | Health Technology |
CymaBay Therapeutics, Inc.
CymaBay Therapeutics, Inc. BiotechnologyHealth Technology CymaBay Therapeutics, Inc. engages in the provision and development of access to therapies for patients with liver and other chronic diseases with high unmet medical needs. Its products pipeline includes Seladelpar, MBX-2982, CB-0406, and CB-001. The company was founded on October 5, 1988 and is headquartered in Newark, CA. | Health Technology |
Triton Biosciences, Inc. |
- Stock Market
- Insiders
- David W. Pritchard